The Product Journal Facebook ad: “If you've been burned by hair products. please read this”

About this ad

Meta Ad Library ID

1749265012883358

Platforms

Facebook, Instagram, Audience Network, Messenger and Threads

Relaunches

0

Niche

Hair Care

How we count

Ad text

To the woman who has itemized her hair loss spending in her head, knows exactly which products failed her and why, and has been using that knowledge to make better choices that are still not producing different results. I had that exact knowledge for years. What I did not have is what I eventually found when I stopped evaluating products by mechanism alone and started evaluating them by whether the delivery system could actually reach the mechanism. That addition to my criteria changed everything the mechanism knowledge alone never had. I have been in this category for eleven years. Not casually. The way you are in a category when you have a problem that does not resolve and you are the kind of person who responds to unresolved problems by understanding them completely. I read the peer-reviewed literature. I understand the 5-alpha-reductase pathway and what DHT does to the dermal papilla during the anagen phase and why the miniaturization progresses the way it progresses. I can tell you the difference between a brand-funded data sheet and an independently replicated clinical study and why that difference matters when you are evaluating an efficacy claim. I also have a mental ledger that goes back eleven years and runs to a number I have decided not to calculate precisely because I did it once and the result was not useful. The Trybello auto-ship I disputed with my bank after three cancellation attempts produced automated responses. The Kilgour MD serum that arrived reformulated with a scent that turned my white hair yellow and came in a dropper that could not dispense the viscosity of the formula it was supposed to deliver. The Ordinary scalp serum that gave me closed comedones across my entire scalp within two weeks and did nothing measurable for the shedding it claimed to address. The supplement combinations I ran for eighteen months each, evaluating iron, ferritin, B12, and Nutrafol in sequence, with bloodwork before and after to control for confounding variables. I kept records. I changed one variable at a time the way you are supposed to. I evaluated the outcomes with the same rigor I brought to the selection. And the thinning progressed through all of it. What I did with each failure is what I have always done. I added it to the ledger. I updated my criteria. I used the failure to make a better next selection. I got progressively more sophisticated in my evaluation framework while the thinning continued to progress at a pace that my increasingly sophisticated framework was not slowing. For a long time I experienced that as a research problem. Something I had not yet understood precisely enough. A mechanism I had not correctly identified or a product I had not evaluated carefully enough against it. What I eventually had to consider is that the research framework itself had a gap. Not in the mechanism knowledge. In the question the mechanism knowledge was training me to ask. I had been asking: does this product target the right mechanism? I had not been asking: can this product's delivery system reach the location where that mechanism is operating? Those are not the same question. And the difference between them is where eleven years of correct mechanism knowledge went to produce no scalp-level result. Here is what I mean precisely. The menopausal hair thinning I had been researching and treating for eleven years has a specific cause at a specific location. When estrogen declines, 5-alpha-reductase converts testosterone to DHT at an elevated rate. DHT binds to androgen receptors in the dermal papilla. The dermal papilla is at the base of the hair follicle. The hair follicle is at the scalp surface. The scalp surface is underneath the strand. Every mechanism I had evaluated in eleven years was correct. DHT inhibition is the right target. Follicular support is the right goal. The actives I had selected, Capixyl, topical caffeine, various peptide combinations, were targeting the right mechanism. What I had never evaluated is whether the delivery system of any of those products could actually reach the scalp surface where the mechanism was operating. The supplements I took worked inside my digestive system and dispersed through my bloodstream. The bloodstream does not concentrate at the scalp. It distributes. Whatever arrived at my scalp arrived diluted across my entire systemic circulation and with no mechanism for localizing at the follicle specifically. I had been treating a local problem with a systemic delivery system for years and evaluating the actives without evaluating the vehicle they came in. The topical treatments I tried had a different problem. Heavy oils and oil-based serums cannot penetrate through the hair cuticle to the scalp surface. The molecular structure is too large for the opening. They sit on the strand and condition the surface while the follicle underneath stays unreached. I had been applying things to the right general area with a delivery system that could not reach the specific location within that area. I had the mechanism right. I had the delivery system wrong. And I had been evaluating the first without including the second in my criteria for eleven years. I am not the only researcher who arrived at this gap through the same sequence. When I went looking specifically for literature on topical delivery and scalp absorption after I identified this as the missing variable in my framework, I found that the women in research communities who had been doing the same kind of rigorous self-directed evaluation had been converging on the same conclusion independently. The mechanism knowledge was widely shared in those communities. The delivery gap was less discussed, and when it was discussed it was discussed in terms of vehicle selection rather than product selection. Water-based versus oil-based. Molecular weight and cuticle permeability. Localized delivery versus systemic dispersal. The distinction that the research communities were making was between what a product targets and whether it can reach what it targets. I had been selecting for the first. The second was the variable I had been missing. What I went looking for after I added delivery system to my criteria was something I had not previously been searching for: a water-based vehicle specifically formulated to absorb into the scalp surface, carrying actives to the follicle environment rather than sitting on the strand or dispersing through the bloodstream. I applied the same criteria I apply to everything. No subscription model. Full ingredient transparency before purchase. No proprietary blend obscuring what the formula actually contains. No alcohol profile that would produce the scalp reactions The Ordinary had given me. Actives with a mechanistic rationale for DHT-relevant scalp support, delivered in a vehicle that could reach the scalp rather than work around it. I found one product that met every criterion. Not because it was the best marketed or the most prominently positioned. Because when I added delivery system to my evaluation, it was the only formulation in the category that was built around reaching the follicle rather than around what the marketing required. I did not order it immediately. I read the formulation three times across two days. I cross-referenced the vehicle against what I now knew about cuticle permeability and water-based absorption. I looked for every variable that had failed me before. I ordered it on the third day. Not because I had decided to trust the claims. Because I had decided the formulation passed the updated criteria, which is a different and more defensible threshold. The formula absorbed into my scalp the way a water-based vehicle absorbs when there is nothing in it working against the process. No residue. No scalp reaction. No comedones. The delivery reached the scalp surface rather than sitting on the strand, which is what I had been trying to solve for since I understood that the delivery gap was the missing variable. I am not telling you it reversed my thinning. Eleven years in this category has made me precise about the difference between what I can claim and what I observed. What I observed is the first topical in eleven years that was built to reach the location I had been targeting, and the first measurable change in the rate of what I had been watching in the mirror. When I went to look for it on the platforms I normally use I found what the category looks like when delivery system is not part of the selection criteria. Supplements acting systemically. Oil-based treatments sitting on the strand. Clinical drugs with side effect profiles I had already evaluated and declined. Nothing built around water-based localized scalp delivery for hormonal thinning as a distinct product category. That category does not exist on those platforms yet because the platforms are organized around the same question I had been asking for eleven years, and the updated question has not yet become a searchable shelf. I am leaving the link here because I know exactly what it costs to spend a decade building a rigorous evaluation framework and watching it produce no result. If there is a woman reading this who has the mechanism knowledge and the product history and the updated criteria that still are not selecting for something that works, I want her to have the variable I was missing before she spends another year applying correct mechanism knowledge to the wrong delivery question. The link is below. Type CRITERIA below if you have been evaluating hair loss products rigorously for years and are still watching the thinning progress anyway.

Where the ad sends people

aakyro.com

If you've been burned by hair products... please read this ☝️

aakyro